Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Cantor Fitzgerald
Baxter
Covington
Federal Trade Commission
Deloitte
AstraZeneca
Medtronic
Moodys

Generated: June 22, 2018

DrugPatentWatch Database Preview

CYLERT Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

When do Cylert patents expire, and when can generic versions of Cylert launch?

Cylert is a drug marketed by Abbott and is included in two NDAs.

The generic ingredient in CYLERT is pemoline. There are seven drug master file entries for this compound. Additional details are available on the pemoline profile page.
Summary for CYLERT
Drug patent expirations by year for CYLERT
Medical Subject Heading (MeSH) Categories for CYLERT
Synonyms for CYLERT
(+)-PEMOLINE
101053-01-4
2-amino-5-phenyl-1,3-oxazol-4-one
2-Amino-5-phenyl-1,3-oxazol-4(5H)-one
2-Amino-5-phenyl-1,3-oxazol-4(5H)-one #
2-amino-5-phenyl-4-oxazolone
2-Amino-5-phenyl-4(5H)-oxazolone
2-Amino-5-phenyl-oxazol-4-one
2-Amino-5-phenyl4(5H)-oxazolone
2-azanyl-5-phenyl-1,3-oxazol-4-one
2-Imino-4-keto-5-phenyltetrahydrooxazole
2-Imino-5-phenyl-4-oxazolidinone
2-Inino-5-phenyloxazolidin-4-one
2-Oxazolin-4-one, 2-amino-5-phenyl-
2152-34-3
2933-45-1
4-Oxazolidinone, 2-imino-5-phenyl-
4-Oxo-2-imino-5-phenyloxazlidine
4(5H)-Oxazolone, 2-amino-5-phenyl-
5-Phenyl-2-imino-4-oxazolidinone
5-Phenyl-2-imino-4-oxo-oxazolidin
5-Phenyl-2-imino-4-oxooxazolidine
5-Phenylisohydantion
A 13397
A800319
A815446
Abbott 13397
AC-22513
AC1L1IT8
AI3-61124
AKOS005065730
AKOS015888248
AN-50464
AOB87716
API0000754
AS-17043
Azoksodon
Azoxodon
Azoxodone
Betanamin
C- 293
C07899
CAS-2152-34-3
CCG-100848
Centramin
CHEBI:7953
CHEMBL1177
Constimol
CPD000238142
CS 293
Cylert (TN)
Cylert Chewable
D00744
D0D5GG
Dantromin
DB01230
DEA No. 1530
Deltamin
Deltamin (VAN)
Deltamine
DSSTox_CID_3427
DSSTox_GSID_23427
DSSTox_RID_81815
DTXSID3023427
EINECS 218-438-8
Endolin
Fenoxazol
Fio
FT-0603591
FT-0655727
FWH-352
H 310
H 3104
HE037848
HE249135
HE325393
HE382045
HMS2051C08
HMS3393C08
HSDB 3148
Hyton
Hyton asa
I01-1045
I01-1046
InChI=1/C9H8N2O2/c10-9-11-8(12)7(13-9)6-4-2-1-3-5-6/h1-5,7H,(H2,10,11,12)
Juston-Wirkstoff
Kethamed
LA 956
LS-100630
Magnesium pemoline
MFCD00083197
MLS000759491
MLS001424026
Myamin
NC00098
NCGC00246967-01
NCGC00246967-02
Nitan
Notair
NPL 1
NRNCYVBFPDDJNE-UHFFFAOYSA-
NRNCYVBFPDDJNE-UHFFFAOYSA-N
NSC 169499
NSC 25159
NSC-169499
NSC-25159
NSC169499
NSC25159
Okodon
P 10
P0392
Pemolide
Pemolin
Pemolina
Pemolina [DCIT]
Pemolina [Italian]
pemoline
Pemoline (including organometallic complexes and chelates thereof)
Pemoline (JAN/USAN/INN)
Pemoline [USAN:INN:BAN:JAN]
Pemoline Compounds
pemoline HCl
pemoline hydrochloride
Pemoline, >=98% (HPLC)
Pemolinum
Pemolinum [INN-Latin]
Phenalone
Phenilone
pheniminooxazolidino
Pheniminooxazolidinone
Phenoxazole
Phenylisohydantoin
phenylpseudohydantoi
Phenylpseudohydantoin
PIO
Pioxol
Pn/135
Pomoline
Pondex
PT 360
Ronyl
SAM001246706
SBB063266
SCHEMBL41636
Senior
Sigmadyn
Sistra
Sistral
SMR000238142
Sofro
Stimul
Stimulol
Tox21_112509
Tox21_112509_1
Tradon
Tradone
Volital
Volitol
W-107545
WLN: T5OYMV EHJ BUM ER
Yh 1

US Patents and Regulatory Information for CYLERT

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Abbott CYLERT pemoline TABLET, CHEWABLE;ORAL 017703-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Abbott CYLERT pemoline TABLET;ORAL 016832-003 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Abbott CYLERT pemoline TABLET;ORAL 016832-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Abbott CYLERT pemoline TABLET;ORAL 016832-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Colorcon
Fuji
Federal Trade Commission
Healthtrust
Farmers Insurance
Mallinckrodt
AstraZeneca
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.